These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2365864)

  • 1. Bumetanide-induced pseudoporphyria.
    Leitao EA; Person JR
    J Am Acad Dermatol; 1990 Jul; 23(1):129-30. PubMed ID: 2365864
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudoporphyria caused by nabumetone.
    Varma S; Lanigan SW
    Br J Dermatol; 1998 Mar; 138(3):549-50. PubMed ID: 9580823
    [No Abstract]   [Full Text] [Related]  

  • 3. Naproxen pseudoporphyria in a patient with vitiligo.
    Burns DA
    Clin Exp Dermatol; 1987 Jul; 12(4):296-7. PubMed ID: 3427818
    [No Abstract]   [Full Text] [Related]  

  • 4. Isotretinoin-associated pseudoporphyria.
    Riordan CA; Anstey A; Wojnarowska F
    Clin Exp Dermatol; 1993 Jan; 18(1):69-71. PubMed ID: 8440060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Furosemide challenge in patients with heart failure and adverse reactions to sulfa-containing diuretics.
    Earl G; Davenport J; Narula J
    Ann Intern Med; 2003 Feb; 138(4):358-9. PubMed ID: 12585844
    [No Abstract]   [Full Text] [Related]  

  • 6. Torsemide-induced pseudoporphyria.
    Pérez-Bustillo A; Sánchez-Sambucety P; Suárez-Amor O; Rodríiguez-Prieto MA
    Arch Dermatol; 2008 Jun; 144(6):812-3. PubMed ID: 18559783
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudoporphyria from nonsteroidal antiinflammatory drugs.
    Taylor BJ; Duffill MB
    N Z Med J; 1987 May; 100(824):322-3. PubMed ID: 3451093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug information: therapeutic main group: diuretics. 10. High-ceiling diuretics (furosemide, bumetanide, ethacrynic acid)].
    Lumholtz IB
    Sygeplejersken; 1978 Dec; 78(48):29. PubMed ID: 252293
    [No Abstract]   [Full Text] [Related]  

  • 9. Bullous pemphigoid induced by bumetanide.
    Boulinguez S; Bernard P; Bedane C; le Brun V; Bonnetblanc JM
    Br J Dermatol; 1998 Mar; 138(3):548-9. PubMed ID: 9580822
    [No Abstract]   [Full Text] [Related]  

  • 10. Naproxen-induced pseudoporphyria: appearance of new skin lesions after discontinuation of treatment.
    Girschick HJ; Hamm H; Ganser G; Huppertz HI
    Scand J Rheumatol; 1995; 24(2):108-11. PubMed ID: 7747141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudoporphyria due to naproxen.
    Mayou S; Black MM
    Br J Dermatol; 1986 Apr; 114(4):519-20. PubMed ID: 3964553
    [No Abstract]   [Full Text] [Related]  

  • 12. Bumetanide-induced hyperamylaseaemia in patients with renal insufficiency.
    Lynggaard F; Bjørndal N
    Lancet; 1977 Dec 24-31; 2(8052-8053):1355. PubMed ID: 74755
    [No Abstract]   [Full Text] [Related]  

  • 13. Chlorthalidone-induced pseudoporphyria: clinical and microscopic findings of a case.
    Baker EJ; Reed KD; Dixon SL
    J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):1026-9. PubMed ID: 2808818
    [No Abstract]   [Full Text] [Related]  

  • 14. Sunbed pseudoporphyria induced by nalidixic acid.
    Bilsland D; Douglas WS
    Br J Dermatol; 1990 Oct; 123(4):547. PubMed ID: 2095188
    [No Abstract]   [Full Text] [Related]  

  • 15. Indomethacin-bumetanide interaction: an alert.
    Ahmad S
    Am J Cardiol; 1984 Jul; 54(1):246-7. PubMed ID: 6741834
    [No Abstract]   [Full Text] [Related]  

  • 16. Pseudoporphyria due to naproxen.
    Lancet; 1985 May; 1(8438):1166-7. PubMed ID: 2860374
    [No Abstract]   [Full Text] [Related]  

  • 17. Reports of adverse reactions with bumetanide.
    Cuthbert MF
    Postgrad Med J; 1975; 51 Suppl 6():51-52. PubMed ID: 1197202
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous moderate-dose bumetanide continuous infusion and severe musculoskeletal pain.
    Vaduganathan M; Allegretti AS; Manchette AM; Patel SS; Olson KR; Bazari H
    Int J Cardiol; 2013 Sep; 168(1):e29-31. PubMed ID: 23727101
    [No Abstract]   [Full Text] [Related]  

  • 19. Pseudoporphyria cutanea tarda induced by furosemide in a patient undergoing peritoneal dialysis.
    Breier F; Feldmann R; Pelzl M; Gschnait F
    Dermatology; 1998; 197(3):271-3. PubMed ID: 9812036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudoporphyria complicating etretinate therapy.
    McDonagh AJ; Harrington CI
    Clin Exp Dermatol; 1989 Nov; 14(6):437-8. PubMed ID: 2605807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.